Search Results - "Bate, Clive"

Refine Results
  1. 1

    Monomeric amyloid-β reduced amyloid-β oligomer-induced synapse damage in neuronal cultures by Bate, Clive, Williams, Alun

    Published in Neurobiology of disease (01-03-2018)
    “…Alzheimer's disease is a progressive neurodegenerative disease characterized by the accumulation of amyloid-β (Aβ) in the brain. Aβ oligomers are believed to…”
    Get full text
    Journal Article
  2. 2

    Sialic Acid on the Glycosylphosphatidylinositol Anchor Regulates PrP-mediated Cell Signaling and Prion Formation by Bate, Clive, Nolan, William, Williams, Alun

    Published in The Journal of biological chemistry (01-01-2016)
    “…The prion diseases occur following the conversion of the cellular prion protein (PrPC) into disease-related isoforms (PrPSc). In this study, the role of the…”
    Get full text
    Journal Article
  3. 3

    Can we switch production of toxic Aβ oligomers to neuroprotective Aβ monomers to allow synapse regeneration by Bate, Clive

    Published in Neural regeneration research (01-09-2017)
    “…Alzheimer's disease (AD) is a complex neurological disor- der characterized by a progressive dementia. The amyloid hypothesis states that pathogenesis is…”
    Get full text
    Journal Article
  4. 4

    Sialic Acid within the Glycosylphosphatidylinositol Anchor Targets the Cellular Prion Protein to Synapses by Bate, Clive, Nolan, William, McHale-Owen, Harriet, Williams, Alun

    Published in The Journal of biological chemistry (12-08-2016)
    “…Although the cellular prion protein (PrPC) is concentrated at synapses, the factors that target PrPC to synapses are not understood. Here we demonstrate that…”
    Get full text
    Journal Article
  5. 5

    Enhanced neuronal degradation of amyloid-β oligomers allows synapse regeneration by Bate, Clive

    Published in Neural regeneration research (01-05-2015)
    “…The amyloid hypothesis of Alzheimer's disease (AD) pathogen- esis maintains that the key event is the production of specific C-terminal amyloid-β (Aβ) peptides…”
    Get full text
    Journal Article
  6. 6

    GPI-anchor signal sequence influences PrPC sorting, shedding and signalling, and impacts on different pathomechanistic aspects of prion disease in mice by Puig, Berta, Altmeppen, Hermann C, Linsenmeier, Luise, Chakroun, Karima, Wegwitz, Florian, Piontek, Ulrike K, Tatzelt, Jörg, Bate, Clive, Magnus, Tim, Glatzel, Markus

    Published in PLoS pathogens (01-01-2019)
    “…The cellular prion protein (PrPC) is a cell surface glycoprotein attached to the membrane by a glycosylphosphatidylinositol (GPI)-anchor and plays a critical…”
    Get full text
    Journal Article
  7. 7

    α-Synuclein-induced synapse damage in cultured neurons is mediated by cholesterol-sensitive activation of cytoplasmic phospholipase A2 by Bate, Clive, Williams, Alun

    Published in Biomolecules (Basel, Switzerland) (09-03-2015)
    “…The accumulation of aggregated forms of the α-synuclein (αSN) is associated with the pathogenesis of Parkinson's disease (PD) and Dementia with Lewy Bodies…”
    Get full text
    Journal Article
  8. 8

    cAMP-Inhibits Cytoplasmic Phospholipase A₂ and Protects Neurons against Amyloid-β-Induced Synapse Damage by Bate, Clive, Williams, Alun

    Published in Biology (Basel, Switzerland) (16-09-2015)
    “…A key event in Alzheimer's disease (AD) is the production of amyloid-β (Aβ) peptides and the loss of synapses. In cultured neurons Aβ triggered synapse damage…”
    Get full text
    Journal Article
  9. 9

    The glycosylphosphatidylinositol anchor is a major determinant of prion binding and replication by Bate, Clive, Tayebi, Mourad, Williams, Alun

    Published in Biochemical journal (28-04-2010)
    “…The prion diseases occur following the conversion of the cellular prion protein (PrPC) into an alternatively folded, disease-associated isoform (PrPSc)…”
    Get more information
    Journal Article
  10. 10

    Squalestatin Cures Prion-infected Neurons and Protects Against Prion Neurotoxicity by Bate, Clive, Salmona, Mario, Diomede, Luisa, Williams, Alun

    Published in The Journal of biological chemistry (09-04-2004)
    “…A key feature of prion diseases is the conversion of the normal, cellular prion protein (PrPC) into β-sheet-rich disease-related isoforms (PrPSc), the…”
    Get full text
    Journal Article
  11. 11

    A camelid anti-PrP antibody abrogates PrP replication in prion-permissive neuroblastoma cell lines by Jones, Daryl Rhys, Taylor, William Alexander, Bate, Clive, David, Monique, Tayebi, Mourad

    Published in PloS one (22-03-2010)
    “…The development of antibodies effective in crossing the blood brain barrier (BBB), capable of accessing the cytosol of affected cells and with higher affinity…”
    Get full text
    Journal Article
  12. 12

    Glycosylphosphatidylinositols: More than just an anchor? by Bate, Clive, Nolan, William, Williams, Alun

    Published in Communicative & integrative biology (03-03-2016)
    “…There is increasing interest in the role of glycosylphosphatidylinositol (GPI) anchors that attach some proteins to cell membranes. Far from being biologically…”
    Get full text
    Journal Article
  13. 13

    Monoacylated Cellular Prion Proteins Reduce Amyloid-β-Induced Activation of Cytoplasmic Phospholipase A2 and Synapse Damage by West, Ewan, Osborne, Craig, Nolan, William, Bate, Clive

    Published in Biology (Basel, Switzerland) (02-06-2015)
    “…Alzheimer's disease (AD) is a progressive neurodegenerative disease characterized by the accumulation of amyloid-β (Aβ) and the loss of synapses. Aggregation…”
    Get full text
    Journal Article
  14. 14

    Interferon-γ increases neuronal death in response to amyloid-β1-42 by Bate, Clive, Kempster, Sarah, Last, Victoria, Williams, Alun

    Published in Journal of neuroinflammation (28-03-2006)
    “…BACKGROUND: Alzheimer's disease is a neurodegenerative disorder characterized by a progressive cognitive impairment, the consequence of neuronal dysfunction…”
    Get full text
    Journal Article
  15. 15

    Clustering of sialylated glycosylphosphatidylinositol anchors mediates PrP-induced activation of cytoplasmic phospholipase A2 and synapse damage by Bate, Clive, Williams, Alun

    Published in Prion (01-09-2012)
    “…Precisely how the accumulation of PrP Sc causes the neuronal degeneration that leads to the clinical symptoms of prion diseases is poorly understood. Our…”
    Get full text
    Journal Article
  16. 16

    Sequestration of free cholesterol in cell membranes by prions correlates with cytoplasmic phospholipase A2 activation by Bate, Clive, Tayebi, Mourad, Williams, Alun

    Published in BMC biology (12-02-2008)
    “…The transmissible spongiform encephalopathies (TSEs), otherwise known as the prion diseases, occur following the conversion of the normal cellular prion…”
    Get full text
    Journal Article
  17. 17

    Phospholipase A2 Inhibitors or Platelet-activating Factor Antagonists Prevent Prion Replication by Bate, Clive, Reid, Stuart, Williams, Alun

    Published in The Journal of biological chemistry (27-08-2004)
    “…A key feature of prion diseases is the conversion of the cellular prion protein (PrP C ) into disease-related isoforms (PrP Sc ), the deposition of which is…”
    Get full text
    Journal Article
  18. 18

    The cellular prion protein with a monoacylated glycosylphosphatidylinositol anchor modifies cell membranes, inhibits cell signaling and reduces prion formation by Bate, Clive, Williams, Alun

    Published in Prion (01-04-2011)
    “…The prion diseases occur following the conversion of the cellular prion protein (PrPC) into a disease-related isoform (PrPSc). In this study a cell painting…”
    Get full text
    Journal Article
  19. 19

    Cholesterol synthesis inhibitors protect against platelet-activating factor-induced neuronal damage by Bate, Clive, Rumbold, Louis, Williams, Alun

    Published in Journal of neuroinflammation (2007)
    “…Platelet-activating factor (PAF) is implicated in the neuronal damage that accompanies ischemia, prion disease and Alzheimer's disease (AD). Since some…”
    Get full text
    Journal Article
  20. 20

    Polyunsaturated Fatty Acids Protect Against Prion-Mediated Synapse Damage In Vitro by Bate, Clive, Tayebi, Mourad, Salmona, Mario, Diomede, Luisa, Williams, Alun

    Published in Neurotoxicity research (01-04-2010)
    “…A loss of synapses is characteristic of the early stages of the prion diseases. Here we modelled the synapse damage that occurs in prion diseases by measuring…”
    Get full text
    Journal Article